HB 5553 West Virginia House of Delegates · 2026 Regular Session

Relating to participation in federal prescription drug pricing programs.

HB 5553 allows West Virginia's Public Employees Insurance Agency (PEIA) and the Department of Human Services to voluntarily join federal prescription drug pricing programs, such as those using international reference pricing models. The bill permits these agencies to negotiate drug prices directly with manufacturers or use federal benchmarks for reimbursement, but only if it saves money for the state and maintains beneficiary access to necessary medications. It explicitly prohibits requiring the state to adopt federal drug lists or override existing state pharmacy benefit rules. Both agencies must report annually to the legislature on program participation, estimated savings, and any access issues.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2026
Committee Review
Floor Vote
Governor
Introduced Feb 16, 2026 Last action Feb 16, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
4
Key actions
0
Committee
2
Feb 16, 2026
Committee
To House Health and Human Resources
lower
Feb 16, 2026
Introduced
Introduced in House
lower
Feb 16, 2026
Committee
To Health and Human Resources
lower
1 primary · 4 co-sponsors

Sponsors